Clinical trial
Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not…
NCT00004149 · Albert Einstein College of Medicine, Other · Completed
Key facts
| NCT number | NCT00004149 |
|---|---|
| Title | Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy |
| Official title | A Phase II Trial of Arsenic Trioxide in Advanced Hormone-Refractory Prostate Cancer |
| Lead sponsor | Albert Einstein College of Medicine, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | arsenic trioxide |
| Enrollment | 37 |
| Start date | Sep 1, 1999 |
| Primary completion | Aug 1, 2003 |
| Completion | Aug 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 17, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: